On Seahorses and Memory

It’s hard to believe it’s been two years since we launched our Neurotrack website. Today, I am excited to unveil both our new look as well as our renewed commitment to the critical area of cognitive health. 

Since our launch, as much has changed as has remained the same. What hasn’t budged is my firm commitment to playing a role in offering a tangible solution to the exponentially growing onslaught of Alzheimer’s cases, as well as providing a new lens through which to think about, care for, and nourish our brains. What has changed is the rapidly increasing body of groundbreaking scientific evidence underscoring the notion that assessing brain health and Alzheimer’s risk as well as intervening early, in our ever-expanding lifespans, can indeed help combat cognitive decline.

Today, we offer a first glimpse into the latest suite of products that Neurotrack will launch commercially in early 2020: an integrated, easy-to-use, universally accessible cognitive assessment; and a customized, multi-domain lifestyle intervention that puts the power of brain health into patients’ own hands.    

The soul, if you will, of our new product can be found in our new logo – two seahorses, facing one another. Why seahorses and why two of them? For one, I love seahorses, those small marine fish in the genus Hippocampus. And of course hippocampus is the Greek word used to name major components in the left and right hemispheres of our brain, which play a key role in the consolidation of short-term and long-term memory. 

Our new logo

Seahorses also mate for life, and it is now becoming clear that social engagement is critical for both memory preservation and for keeping cognitive decline at bay. Our logo of two seahorses facing one another, as they are so often seen in the wild, is therefore rooted in this analogy of connectivity, both out in the world and within the confines of the brain itself.

I created Neurotrack to combat the uncertainty and fear associated with Alzheimer’s and dementia-related diseases with science and research. Our platform, to be launched in early 2020, will provide both information––a suite of simple at-home assessment tests to set your cognitive baseline and monitor it over time––and actual hope in the form of clinically proven, multi-domain interventions. These interventions were first highlighted in the 2013 FINGER study, and their efficacies were newly proven and expanded-upon via the work of Dr. Richard Isaacson, whose just-published clinical trial entered the mainstream in Wednesday’s Wall Street Journal, as we were relaunching our site. Our product, developed with scientists and doctors, uses groundbreaking eye-tracking technology as the centerpiece of a holistic program to measure, manage, and sharpen mental acuity.  

The most exciting part of what we’ll be bringing you is a way for you to understand your cognitive health and your own specific risks for developing dementia in the comfort of your own home, via a camera-enabled device such as your phone, a tablet, or a personal computer and a few minutes of your time. Armed with this information, you will be able to first talk with your doctor, then sign up for our customized cognitive health program offering lifestyle interventions addressing your specific needs in six key areas: sleep, stress, diet, exercise, social engagement, and cognitive training.  

Measure your cognitive abilities in the privacy of your own home.

I am thrilled to be on the brink of providing real tools I promised myself I might one day build as I watched my grandparents disappear into the abyss of Alzheimer’s – to offer more than hope of a cure at some nebulous point in an unspecified future, but rather a way of recognizing potential risk today, to intervene early, and to prevent decline before the onset of cognitive decline.

So, welcome to the family, Neurotrack seahorses. And may you serve as further inspiration both to our team on the ground and to the population at large. If seahorse males can carry the babies, surely we can change the Alzheimer’s paradigm as well. 

Elli Kaplan

Founder & CEO of Neurotrack — Elli Kaplan is on a mission to change the conversation around the diagnosis and prevention of cognitive decline.